相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
Kyohei Nakamura et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
Junyu Long et al.
EBIOMEDICINE (2019)
Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas
Yi-Wen Hsiao et al.
GENES (2019)
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
Xuanwen Bao et al.
FRONTIERS IN ONCOLOGY (2019)
Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
Katarzyna Szewczyk et al.
FRONTIERS IN ONCOLOGY (2019)
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
Xiangyang Deng et al.
FRONTIERS IN ONCOLOGY (2019)
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective
Palanisamy Nallasamy et al.
SEMINARS IN CANCER BIOLOGY (2018)
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma
Diede Brunen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
Thitinee Vanichapol et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Classification of triple-negative breast cancers based on Immunogenomic profiling
Yin He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma
Yi Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
Valentina Rigo et al.
SCIENTIFIC REPORTS (2017)
The MYCN Protein in Health and Disease
Maria Victoria Ruiz-Perez et al.
GENES (2017)
MYCN amplification is associated with repressed cellular immunity in neuroblastoma: an In Silico immunological analysis of TARGET Database
Peng Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data
Walid M. Abdelmoula et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R. Pinto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
Marco Mina et al.
ONCOIMMUNOLOGY (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
Giuseppe Barone et al.
CLINICAL CANCER RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
分享论文
